Reviews are an excellent way to keep up-to-date on the latest trends and technologies in your field. Hepatic Cell News features at least one new review article every week, each of which is archived here on this page. Sort by title, journal, publication date or newsletter issue to find what you need. You can also submit recent review articles to our editorial team here.
Title   Journal   Publication Date   Newsletter Issue  
The Epigenetic Drug Discovery Landscape for Metabolic-Associated Fatty Liver Disease
Bayoumi, A.; Grønbæk, H.; George, J.; Eslam, M.
Trends Genet 2020-03-28 4.12 | Apr 2
Cancer Stemness in Hepatocellular Carcinoma: Mechanisms and Translational Potential
Tsui, Y.; Chan, L.; Ng, I.
Br J Cancer 2020-04-02 4.12 | Apr 2
Regulation and Function Of Capicua In Mammals
Lee, Y.
Exp Mol Med 2020-04-01 4.12 | Apr 2
Beneficial Effects of the Ketogenic Diet on Nonalcoholic Fatty Liver Disease: A Comprehensive Review of the Literature
Watanabe, M.; Tozzi, R.; Risi, R.; Tuccinardi, D.; Mariani, S.; Et al.
Obes Rev 2020-03-24 4.11 | Mar 27
Lysyl Oxidase (LOX) Family Members: Rationale and Their Potential as Therapeutic Targets for Liver Fibrosis
Chen, W.; Yang, A.; Jia, J.; Popov, Y.; Schuppan, D.; You, H.
Hepatology 2020-03-16 4.10 | Mar 20
The Cancer Stem Cell in Hepatocellular Carcinoma
Schulte, L.; López-Gil, J.; Sainz, B. Hermann, P.
Cancers 2020-03-14 4.10 | Mar 20
Biology and Clinical Application of Regulatory RNAs in Hepatocellular Carcinoma
Pea, A.; Jamieson, N.; Braconi, C.
Hepatology 2020-03-11 4.09 | Mar 13
Immune-Based Therapies for Hepatocellular Carcinoma
Pinato, D.; Guerra, N.; Fessas, P.; Murphy, R.; Mineo, T.
Oncogene 2020-03-10 4.09 | Mar 13
One-Carbon Metabolism in Fatty Liver Disease and Fibrosis: One-Carbon to Rule Them All
Silva, R.; Eudy, B.; Deminice, R.
J Nutr 2020-03-02 4.08 | Mar 6
The Role of Sphingolipid Pathway in Liver Fibrosis: An Emerging New Potential Target for Novel Therapies
Ishay, Y.; Nachman, D.; Khoury, T.; Ilan, Y.
Am J Physiol Cell Physiol 2020-03-04 4.08 | Mar 6
Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma
Dimri, M; Satyanarayana, A
Cancers 2020-02-20 4.07 | Feb 28
Advances in Non-Invasive Assessment of Hepatic Fibrosis
Loomba, R.; Adams, L.
Gut 2020-02-17 4.06 | Feb 21
Synthetic Lethality: A Promising Therapeutic Strategy for Hepatocellular Carcinoma
Tang, L.; Chen, .; Xu, X.
Cancer Lett 2020-02-16 4.06 | Feb 21
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease
Eslam, M.; Sanyal, A.; George, J.
Gastroenterology 2020-02-07 4.05 | Feb 14
Human Antigen R: A Potential Therapeutic Target for Liver Diseases
Liu, R.; Wu, K.; Li, Y.; Sun, R.; Li, X.
Pharmacol Res 2020-02-08 4.05 | Feb 14
Evolving Cell-Based and Cell-Free Clinical Strategies for Treating Severe Human Liver Diseases
Cernigilaro, V.; Peluso, R.; Zedda, B.; Silengo, L.; Tolosano, E.; Et al.
Cells 2020-02-07 4.05 | Feb 14
Extracellular Vesicles, a Possible Theranostic Platform Strategy for Hepatocellular Carcinoma-an Overview
D’Agnano, I.; Beradi, A.
Cancers 2020-01-21 4.03 | Jan 31
Targeting FGF21 for the Treatment of Nonalcoholic Steatohepatitis
Zarei, M.; Pizarro-Delgado, J.; Barroso, E.; Palomer, X.; Vázquez-Carrera, M.
Trends Pharmacol Sci 2020-01-21 4.02 | Jan 24
The Matrisome, Inflammation, and Liver Disease
Dolin, C.; Arteel, G.
Semin Liver Dis 2020-01-07 4.01 | Jan 17
Developments in Predictive Biomarkers for Hepatocellular Carcinoma Therapy
Andrea, C.; Giulia, O.; Francesco, C.; Giorgio, E.
Expert Rev Anticancer Ther 2020-01-07 4.01 | Jan 17
Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
Romeo, S.; Sanyal, A.; Valenti, L.
Cell Metab 2020-01-07 4.00 | Jan 10
Liver-on-a-Chip Models of Fatty Liver Disease
Hassan, S.; Sebastian, S.; Maharjan, S.; Lesha, A.; Carpenter, A.; Et al.
Hepatology 2020-01-07 4.00 | Jan 10
Autophagy in Hepatic Adaptation to Stress
Hazari, Y; Et Al.
J Hepatol 2019-12-18 3.48 | Dec 20
Organoids for Liver Stage Malaria Research
Mellin, R; Boddey, JA
Trends Parasitol 2019-12-14 3.48 | Dec 20
A Hepatic Scaffold from Decellularized Liver Tissue: Food for Thought
Croce, S.; Peloso, A.; Zoro, T.; Avanzini, M.; Cobianchi, L.
Biomolecules 2019-12-02 3.47 | Dec 13
Tumor Evolution in Hepatocellular Carcinoma Craig, A.; von Felden, J.; Garcia-Lezana, T.; Sarcognato, S.; Villaneuva, A. Nat Rev Gastroenterol Hepatol 2019-12-02 3.46 | Dec 6
The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis Sartorius, K.; Makarova, J.; Sartorius, B.; An, P.; Winkler, C.; Et al. Cells 2019-11-24 3.45 | Nov 29
The Many Roles of Cell Adhesion Molecules in Hepatic Fibrosis Hintermann, E.; Christen, U. Cells 2019-11-24 3.45 | Nov 29
Western Diet and the Immune System: An Inflammatory Connection Christ, A.; Lauterbach, M.; Latz, E. Immunity 2019-11-19 3.44 | Nov 22
A Role for the Biological Clock in Liver Cancer Mazzoccoli, G.; Miele, L.; Marrone, G.; Mazza, T.; Vinciguerra, M.; Grieco, A. Cancers 2019-11-11 3.43 | Nov 15
TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis Dewidar, B.; Meyer, C.; Dooley, S.; Meindl-Beinker, N. Cells 2019-11-11 3.43 | Nov 15
Emerging Agents and Regimens for Hepatocellular Carcinoma Zhu, X.; Sun, H. J Hematol Oncol 2019-10-26 3.42 | Nov 8
Recreating Tumor Complexity in a Dish: Organoid Models to Study Liver Cancer Cells and Their Extracellular Environment Tienderen, G.; Koerkamp, B.; Ijzermans, J.; Laan, L.; Verstegan, M. Cancers 2019-11-01 3.42 | Nov 8
Metabolic Rearrangements in Primary Liver Cancers: Cause and Consequences Satriano, L.; Lewinska, M.; Rodrigues, P.; Banales, J.; Andersen, J. Nat Rev Gastroenterol Hepatol 2019-10-30 3.41 | Nov 1
Emerging Agents and Regimens for Hepatocellular Carcinoma Zhu, X.; Sun, H. J Hematol Oncol 2019-10-26 3.41 | Nov 1
Acetaminophen-Induced Liver Damage in Hepatic Steatosis García-Román, R.; Francés, R. Clin Pharmacol Ther 2019-10-22 3.40 | Oct 25
Roles of Thyroid Hormone-Associated MicroRNAs Affecting Oxidative Stress in Human Hepatocellular Carcinoma Huang, P.; Wang, C.; Yeh, C.; Lin, K. Int J Mol Sci 2019-10-21 3.40 | Oct 25
Dysregulated MicroRNA Fingerprints and Methylation Patterns in Hepatocellular Carcinoma, Cancer Stem Cells, and Mesenchymal Stem Cells Nasr, M.; Salah, R.; Elkodous, M.; Elshenawy, S.; El-Badri, N. Front Cell Dev Biol 2019-10-17 3.39 | Oct 18
Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives Kang, S.; Kim, M.; Eom, Y.; Baik, S. Gut Liver 2019-10-08 3.38 | Oct 11
Purinergic Signaling in Hepatic Disease Velázquez-Miranda, E.; Díaz-Muñoz, M.; Vázquez-Cuevas, F. Purinergic Signal 2019-10-01 3.37 | Oct 4
The Regulation of Hepatic Fatty Acid Synthesis and Partitioning: The Effect of Nutritional State Hodson, L.; Gunn, P. Nat Rev Endocrinol 2019-09-25 3.35 | Sep 27
Anti-Tumoral Activity of Single and Combined Regorafenib Treatments in Preclinical Models of Liver and Gastrointestinal Cancers Fonevila, F.; Méndez-Blanco, C.; Fernández-Palanca, P.; González-Gallego, G.; Mauriz, J. Exp Mol Med 2019-09-24 3.35 | Sep 27
Molecular Mechanisms of Circular RNAs, Transforming Growth Factor-β, and Long Noncoding RNAs in Hepatocellular Carcinoma Machuki, J.; Shang, W.; Adzika, G.; Li, Y.; Huang, Q.; Et al. Cancer Med 2019-09-15 3.35 | Sep 20
Clinical Considerations for Capsid Choice in the Development of Liver-Targeted AAV-Based Gene Transfer Pipe, S.; Leebeek, F.; Ferreira, V.; Sawyer, E.; Pasi, J. Mol Ther Oncolytics 2019-09-10 3.34 | Sep 13
Protective Effects of Polysaccharides on Hepatic Injury: A Review Yuan, Y; Che, L; Qi, C; Meng, Z Int J Biol Macromol 2019-09-02 3.33 | Sep 6
Biology and Significance of Alpha-Fetoprotein in Hepatocellular Carcinoma Galle, P.; Foerster, F.; Kudo, M.; Chan, S.; Llovet, J.; Et al. Liver Int 2019-08-22 3.32 | Aug 30
Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Drescher, H.; Weiskirchen, S.; Weiskirchen, R. Cells 2019-08-07 3.30 | Aug 16
Reversal of NASH Fibrosis with Pharmacotherapy Alukal, J.; Thuluvath, P. Hepatol Int 2019-07-30 3.29 | Aug 9
Immunomodulatory TGF-β Signaling in Hepatocellular Carcinoma Gingold, J.; Chen, J.; Su, X. Trends Mol Med 2019-07-25 3.28 | Aug 2
Reversal of NASH Fibrosis with Pharmacotherapy Aulkal, J.; Thuluvath, P. Hepatol Int 2019-07-30 3.28 | Aug 2
Immunomodulatory TGF-β Signaling in Hepatocellular Carcinoma Chen, J.; GIngold, J.; Su, X. Trends Mol Med 2019-07-25 3.27 | Jul 26
Roles and Regulation of Long Non-Coding RNAs in Hepatocellular Carcinoma Lim, L.; Wong, S.; Huang, F.; Lim, S.; Ooi, L.; Et al. Cancer Res 2019-07-23 3.27 | Jul 26
Research Progress on the Anti-Hepatic Fibrosis Action and Mechanism of Natural Products Shan, L.; Liu, Z.; Ci, L.; Shuai, C.; Lv, X.; Li, J. Int Immunopharmacol 2019-07-20 3.27 | Jul 26
Liver Organoids: From Basic Research to Therapeutic Applications Prior, N.; Inacio, P.; Huch, M. Gut 2019-07-12 3.26 | Jul 19
miRNAs and NAFLD: From Pathophysiology to Therapy Gjorgjieva, M.; Sobolewski, C.; Dolicka, D.; Correia de Sousa, M.; Foti, M. Gut 2019-07-12 3.26 | Jul 19
Circular RNAs in Hepatocellular Carcinoma: Biomarkers, Functions and Mechanisms Qiu, L.; Xu, H.; Ji, M.; Zhang, D.; Lu, Z.; Et al. Life Sci 2019-09-15 3.26 | Jul 19
Immune Checkpoint Inhibitors for Hepatocellular Carcinoma Dika, I.; Khalil, D.; Abou-Alfa, G. Cancer 2019-07-10 3.25 | Jul 12
Current Understanding of Adipose-Derived Mesenchymal Stem Cell-Based Therapies in Liver Diseases Hu, C.; Zhao, C.; Li, L. Stem Cell Res Ther 2019-07-08 3.25 | Jul 12
Stem Cell-Related Studies and Stem Cell-Based Therapies in Liver Diseases Zhou, W; Nelson, ED; Abu Rmilah, AA; Amiot, BP; Nyberg, SL Cell Transplant 2019-06-26 3.24 | Jul 5
The Role of Telomeres and Telomerase in Cirrhosis and Liver Cancer Nault, J-C; Ningarhari, M; Rebouissou, S; Zucman-Rossi, J Nat Rev Gastroenterol Hepatol 2019-06-28 3.23 | Jun 28
The Role of Senescence in the Development of Non-Alcoholic Fatty Liver Disease and Progression to Non-Alcoholic Steatohepatitis Papatheodoridi, A-M; Chrysavgis, L; Koutsilieris, M; Chatzigeorgiou, A Hepatology 2019-06-23 3.23 | Jun 28
Application of Nintedanib and Other Potential Anti-Fibrotic Agents in Fibrotic Diseases Liu, F; Bayliss, G; Zhuang, S Clin Sci (Lond) 2019-06-19 3.22 | Jun 21
Humanized Mouse Models for the Study of Hepatitis C and Host Interactions Yong, K; Her, Z; Chen, Q Cells 2019-06-17 3.22 | Jun 21
ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis Foglia, B; Cannito, S; Bocca, C; Parola, M; Novo, E Int J Mol Sci 2019-06-01 3.21 | Jun 14
Pathobiology of Inherited Biliary Diseases: A Roadmap to Understand Acquired Liver Diseases Fabris, L; Fiorotto, R; Strazzabosco, M; et al Nat Rev Gastroenterol Hepatol 2019-06-05 3.20 | Jun 7
Immune Cell Therapy for Hepatocellular Carcinoma Mizukoshi, E J Hematol Oncol 2019-05-29 3.19 | May 31
Fibrosis in Chronic Liver Disease: An Update on Diagnostic and Treatment Modalities Manka, P; Zeller, A; Syn, W Drugs 2019-05-22 3.18 | May 24
Epigenetic Mechanisms in Hepatic Stellate Cell Activation during Liver Fibrosis and Carcinogenesis Barcena-Varela, M; Colyn, L; Fernandez-Barrena, M Int J Mol Sci 2019-05-21 3.18 | May 24
Roles of Exosomes in Liver Metastases: Novel Diagnosis and Treatment Choices Han, W; Duan, Z J Cell Physiol 2019-05-15 3.17 | May 17
Homeobox Genes and Hepatocellular Carcinoma Liu, K; Wang, L; Hsu, S; Wang, S Cancers 2019-05-03 3.16 | May 10
Technological Advancements for the Development of Stem Cell-Based Models for Hepatotoxicity Testing Natale, A; Vanmol, K; Rodrigues, R; et al Arch Toxicol 2019-04-29 3.15 | May 3
Past, Present and Future Perspectives in Nonalcoholic Fatty Liver Disease Sanyal, A Nat Rev Gastroenterol Hepatol 2019-04-25 3.14 | Apr 26
From NASH to HCC: Current Concepts and Future Challenges Anstee, Q; Reeves, H; Kotsilliti, E; Govaere, O; Heikenwalder, M Nat Rev Gastroenterol Hepatol 2019-04-26 3.14 | Apr 26
Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma Sircana, A; Paschetta, E; Saba, F; Molinaro, F; Musso, G Int J Mol Sci 2019-04-09 3.13 | Apr 12
Sex Differences in NAFLD: State of the Art and Identification of Research Gaps Lonardo, A; Nascimbeni, F; Suzuki, A; et al Hepatology 2019-03-29 3.12 | Apr 5
The Liver-Alpha Cell Axis and Type 2 Diabetes Albreschtsen, N; Pedersen, J; Holst, J; et al Endocr Rev 2019-03-28 3.11 | Mar 29
Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review Kanda, T; Goto, T; Hirotsu, Y; Moriyama, M; Omata, M Int J Mol Sci 2019-03-18 3.10 | Mar 22
Biological Mechanisms and Related Natural Modulators of Liver X Receptor in Nonalcoholic Fatty Liver Disease Ni, M; Zhang, B; Zhao, Y; et al Biomed Pharmacother 2019-03-18 3.10 | Mar 22
Molecular Functions and Clinical Impact of Thyroid Hormone-Triggered Autophagy in Liver-Related Diseases Hsiang Cheng, C; Chung-Ying, T; Ming-Ming, T; Chau-Ting, Y; Kwang-Huei, L J Biomed Sci 2019-03-08 3.09 | Mar 15
Cholangiocyte Pathobiology Banales, J; Huebert, R; Karlsen, T; Strazzabosco, M; LaRusso, N; Gores, G Nat Rev Gastroenterol Hepatol 2019-03-08 3.08 | Mar 8
Connexin and Pannexin (Hemi)Channels: Emerging Targets in the Treatment of Liver Disease Cooreman, A; Van Campenhout, R; Ballet, S; Annaert, P; Van Den Bossche, B; Colle, I; Cogliati, B; Vinken M Hepatology 2019-02-26 3.07 | Mar 1
Hepatoprotective Effects of Rosmarinic Acid: Insight into Its Mechanisms of Action Elufioye, T; Habtemariam, S Biomed Pharmacother 2019-02-16 3.06 | Feb 22
A Literature Review for the Mechanisms of Stress-Induced Liver Injury Joung, J; Cho, J; Kim, Y; Choi, S; Son, C Brain Behav 2019-02-13 3.05 | Feb 15
Review Article: Shared Disease Mechanisms between Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome – Translating Knowledge from Systems Biology to the Bedside Sookoian, S; Pirola, C Aliment Pharmacol Ther 2019-02-04 3.04 | Feb 8
Noncoding RNAs in Alcoholic Liver Disease Li, H; Du, X; Huang, H; Chen, X; Yang, Y; Huang, C; Meng, X; Li, J J Cell Physiol 2019-01-31 3.03 | Feb 1
Gut Microbial Metabolites in Obesity, NAFLD and T2DM Canfora, E; Meex, R; Venema, K; Blaak, E Nat Rev Endocrinol 2019-01-22 3.02 | Jan 25
Therapeutic Advances for Patients with Intermediate Hepatocellular Carcinoma Sun, J; Yin, T; Zhang, Z; Lu, X J Cell Physiol 2019-01-15 3.01 | Jan 18
History and Evolution of Yttrium-90 Radioembolization for Hepatocellular Carcinoma Saini, A; Wallace, A; Alzubaidi, S; Knuttinen, M; naidu, S; Sheth, R; Albadawi, H; Oklu, R J Clin Med 2019-01-07 3.00 | Jan 11
Hepatocellular Carcinoma in β-Thalassemia Patients: Review of the Literature with Molecular Insight into Liver Carcinogenesis Finianos, A; Matar, CF; Taher, A Int J Mol Sci 2018-12-17 2.49 | Dec 21
The Roles of lncRNA in Hepatic Fibrosis Peng, H; Wan, LY; Liang, JJ; Zhang, YQ; Ai, WB; Wu, JF Cell Biosci 2018-12-06 2.48 | Dec 14
Metabolic Aspects in NAFLD, NASH and Hepatocellular Carcinoma: The Role of PGC1 Coactivators Piccinin, E; Villani, G; Moschetta, A Nat Rev Gastroenterol Hepatol 2018-12-05 2.47 | Dec 7
Life Cycle and Morphogenesis of the Hepatitis E Virus Himmelsbach, K; Bender, D; Hildt, E Emerg Microbes Infect 2018-11-29 2.46 | Nov 30
Wnt-β-Catenin Signalling in Liver Development, Health and Disease Perugorria, J; Olaizola, P; Labiano, I; Esparza-Baquer, A; Marzioni, M; Marin, J; Bujanda , L; Banales, J Nat Rev Gastroenterol Hepatol 2018-11-19 2.45 | Nov 23
Preclinical Models for Studying NASH-Driven HCC: How Useful Are They? Febbraoi, M; Reibe, S; Shalapour, S; Ooi, G; Watt, M; Karin, M Cell Metab 2018-11-15 2.44 | Nov 16
Involvement of 5′-Activated Protein Kinase in the Effects of Resveratrol on Liver Steatosis Trepiana, J; Milton-Laskibar, I; Gómez-Zorita, S; Eseberri, I; González, M; Fernández-Quintela, A; Portillo, MP Int J Mol Sci 2018-11-05 2.43 | Nov 9
Challenges and Opportunities in the Clinical Development of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma Flynn, MJ; Sayed, AA; Sharma, R; Siddique, A; Pinato, DJ Hepatology 2018-01-01 2.42 | Nov 2
Lipid Mediators of Liver Injury in Nonalcoholic Fatty Liver Disease Liangpunsakul, S; Chalasani, N Am J Physiol Gastrointest Liver Physiol 2018-01-01 2.42 | Nov 2
Molecular Pathways of Nonalcoholic Fatty Liver Disease Development and Progression Bessone, F; Razori, MV; Roma, MG Cell Mol Life Sci 2018-10-20 2.41 | Oct 26
Chemical Induction of Hepatic Apoptosis in Rodents Qinna, NA; Ghanim, BY J Appl Toxicol 2018-10-23 2.41 | Oct 26
Cell Death in Cancer in the Era of Precision Medicine Raschellà, G; Melino, G; Gambacurta, A Genes Immun 2018-10-19 2.40 | Oct 19
Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression from NAFLD to NASH Pierantonelli, I; Svegliati-Baroni, G Transplantation 2018-10-08 2.39 | Oct 12
Gut Microbiota’s Relationship with Liver Disease and Role in Hepatoprotection by Dietary Natural Products and Probiotics Meng, X; Li, S; Li, Y; Gan, RY; Li, HB Nutrients 2018-10-08 2.39 | Oct 12
Molecular Mechanisms of Hepatocarcinogenesis Following Sustained Virological Response in Patients with Chronic Hepatitis C Virus Infection Hayes, N; Zhang, P; Zhang, Y; Chayama, K Viruses 2018-09-28 2.38 | Oct 5
Apoptosis and Necroptosis in the Liver: A Matter of Life and Death Schwabe, RF; Luedde, T Nat Rev Gastroenterol Hepatol 2018-09-24 2.37 | Sep 28
Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances Sirica, AE; Gores, GJ; Groopman, JD; Selaru, FM; Strazzabosco, M; Wang, XW; Zhu, AX Hepatology 2018-09-25 2.37 | Sep 28
Non-Coding RNA in Drug Resistance of Hepatocellular Carcinoma Ding, B; Lou, W; Xu, L; Fan, W Biosci Rep 2018-09-17 2.36 | Sep 21
High-Mobility Group Box-1 and Liver Disease Gaskell, H; Ge, X; Nieto, N Catal Commun 2018-09-07 2.35 | Sep 14
Innovation for Hepatotoxicity In Vitro Research Models: A Review Han, W; Wu, Q; Zhang, X; Duan, Z J Appl Toxicol 2018-09-05 2.34 | Sep 7
Liver Regeneration in Aged Mice: New Insights Pibiri, M Aging (Albany NY) 2018-08-28 2.33 | Aug 31
Novel Targeted Treatment Options for Advanced Cholangiocarcinoma Mahipal, A; Kommalapati, A; Tella, SH; Lim, A; Kim, R Expert Opin Investig Drugs 2018-08-20 2.32 | Aug 24
Advances in Engineered Human Liver Platforms for Drug Metabolism Studies Underhill, GH; Khetani, SR Drug Metab Dispos 2018-08-22 2.32 | Aug 24
Alcoholic Liver Disease Seitz, HK; Bataller, R; Cortez-Pinto, H; Gao, B; Gual, A; Lackner, C; Mathurin, P; Mueller, S; Szabo, G; Tsukamoto, H Nat Rev Dis Primers 2018-08-16 2.31 | Aug 17
MicroRNAs in Alcoholic Liver Disease: Recent Advances and Future Applications Xu, T; Li, L; Hu, HQ; Meng, XM; Huang, C; Zhang, L; Qin, J; Li, J J Cell Physiol 2018-08-04 2.30 | Aug 10
Molecular Therapies and Precision Medicine for Hepatocellular Carcinoma Llovet, JM; Montal, R; Finn, RS Nat Rev Clin Oncol 2018-07-30 2.29 | Aug 3
Statins: Old Drugs As New Therapy for Liver Diseases? Pose, E; Trebicka, J; Mookerjee, RP; Angeli, P; Ginès, P J Hepatol 2018-08-01 2.29 | Aug 3
Potential Mechanisms Underlying the Role of Coffee in Liver Health Alferink, LJM; Kiefte-de Jong, JC; Darwish Murad, S Semin Liver Dis 2018-07-24 2.28 | Jul 27
Coagulation, Microenvironment and Liver Fibrosis Bitto, N; Liguori, E; La Mura, V Cells 2018-07-24 2.28 | Jul 27
Serum Biomarkers for Diagnosis and Monitoring Viral Hepatitis and Hepatocellular Carcinoma Kotha, S; Neong, S; Keyur, P Expert Rev Mol Diagn 2018-07-18 2.27 | Jul 20
Animal Models of NAFLD from a Hepatologist’s Point of View Jahn, D; Kircher, S; Hermanns, HM; Geier, A Biochim Biophys Acta 2018-07-07 2.26 | Jul 13
Mechanisms of NAFLD Development and Therapeutic Strategies Friedman, SL; Neuschwander-Tetri, BA; Rinella, M; Sanyal, AJ Nat Med 2018-07-02 2.25 | Jul 6
Emerging Role and Therapeutic Implication of Wnt Signaling Pathways in Liver Fibrosis Wang, JN; Li, L; Li, LY; Yan, Q; Li, J; Xu, T Gene 2018-06-23 2.24 | Jun 29
Endoplasmic Reticulum Stress Signaling and the Pathogenesis of Non-Alcoholic Fatty Liver Disease Lebeaupin, C; Vallée, D; Hazari, Y; Hetz, C; Chevet, E; Bailly-Maitre, B J Hepatol 2018-06-22 2.24 | Jun 29
Microphysiological Systems Meet hiPSC Technology – New Tools for Disease Modeling of Liver Infections in Basic Research and Drug Development Raasch, M; Fritsche, E; Kurtz, A; Bauer, M; Mosig, AS Adv Drug Deliv Rev 2018-06-15 2.23 | Jun 22
Mouse Models of Hepatocellular Carcinoma: An Overview and Highlights for Immunotherapy Research Brown, ZJ; Heinrich, B; Greten, TF Nat Rev Gastroenterol Hepatol 2018-06-14 2.22 | Jun 15
Clinico-Pathological Importance of TGF-β/Phospho-Smad Signaling during Human Hepatic Fibrocarcinogenesis Yoshida, K; Matsuzaki, K; Murata, M; Yamaguchi, T; Suwa, K; Okazaki, K Cancers 2018-06-05 2.21 | Jun 8
Noninvasive Biomarkers in NAFLD and NASH — Current Progress and Future Promise Wong, VWS; Adams, LA; Lédinghen, VL; Wong, GLH; Sookoian, S Nat Rev Gastroenterol Hepatol 2018-05-29 2.20 | Jun 1
In Vitro and In Silico Liver Models: Current Trends, Challenges and Opportunities Poloznikov, A; Gazaryan, I; Shkurnikov, M; Nikulin, S; Drapkina, O; Baranova, A; Tonevitsky, A ALTEX 2018-05-28 2.20 | Jun 1
Role of Peroxisome Proliferator-Activated Receptors in Non-Alcoholic Fatty Liver Disease Inflammation Silva, AKS; Peixoto, CA Cell Mol Life Sci 2018-05-22 2.19 | May 25
Novel and Emerging Therapies for Cholestatic Liver Diseases Goldstein, J; Levy, C Liver Int 2018-05-14 2.18 | May 18
Targeting Oxidative Stress for the Treatment of Liver Fibrosis Luangmonkong, T; Suriguga, S; Mutsaers, HAM; Groothuis, GMM; Olinga, P; Boersema, M Rev Physiol Biochem Pharmacol 2018-05-05 2.17 | May 11
Emerging Roles of G Protein-Coupled Receptors in Hepatocellular Carcinoma Peng, WT; Sun, WY; Li, XR; Sun, JC; Du, JJ; Wei, W Int J Mol Sci 2018-05-04 2.17 | May 11
The Prevention of Hepatitis B-Related Hepatocellular Carcinoma Lin, CL; Kao, JH Aliment Pharmacol Ther 2018-05-03 2.16 | May 4
Hepatocyte Transplantation and Advancements in Alternative Cell Sources for Liver-Based Regenerative Medicine Lee, CA; Sinha, S; Fitzpatrick, E; Dhawan, A J Mol Med (Berl) 2018-04-24 2.15 | Apr 27
Understanding Liver Regeneration: From Mechanisms to Regenerative Medicine Gilgenkrantz, H; Collin de l’Hortet, A Am J Pathol 2018-04-16 2.15 | Apr 27
Human Hepatocellular Carcinoma: Protection by Melatonin Mortezaee, K J Cell Physiol 2018-04-19 2.15 | Apr 27
Exosomal miRNAs in Hepatocellular Carcinoma Development and Clinical Responses Li, S; Yao, J; Xie, M; Liu, Y; Zheng, M J Hematol Oncol 2018-04-20 2.14 | Apr 20
Liver Fibrosis: Direct Antifibrotic Agents and Targeted Therapies Schuppan, D; Ashfaq-Khan, M; Yang, AT; Kim, YO Matrix Biol 2018-04-12 2.14 | Apr 20
Augmenter of Liver Regeneration: A Key Protein in Liver Regeneration and Pathophysiology Gupta, P; Venugopal, SK Hepatol Res 2018-04-06 2.13 | Apr 13
Extracellular Adenosine: A Critical Signal in Liver Fibrosis Fausther, M Am J Physiol Gastrointest Liver Physiol 2018-03-29 2.12 | Apr 6
The Hedgehog Pathway in Nonalcoholic Fatty Liver Disease Verdelho Machado, M; Diehl, AM Crit Rev Biochem Mol Biol 2018-03-20 2.11 | Mar 23
The Roles of Protein Tyrosine Phosphatases in Hepatocellular Carcinoma Huang Y; Zhang Y; Ge L; Lin Y; Kwok HF Genes (Basel) 2018-03-20 2.11 | Mar 23
Induced Pluripotent Stem Cells and Precision Medicine in Human Liver Disease Kulkarni, S; Rudnick, DA J Pediatr Gastroenterol Nutr 2018-03-05 2.10 | Mar 16
Schistosome-Induced Fibrotic Disease: The Role of Hepatic Stellate Cells Carson, JP; Ramm, GA; Robinson, MW; McManus, DP; Gobert, GN Trends Parasitol 2018-03-08 2.09 | Mar 9
Hepatitis B Virus-Associated Hepatocellular Carcinoma and Hepatic Cancer Stem Cells Mani, SKK; Andrisani, O Genes (Basel) 2018-03-02 2.09 | Mar 9
Role of Nonresolving Inflammation in Hepatocellular Carcinoma Development and Progression Yu, L-X; Ling, Y; Wang, H-Y npj Precis Oncol 2018-02-23 2.08 | Mar 2
γδ T Cells in Liver Diseases Wang, X; Tian, Z Front Med 2018-02-14 2.07 | Feb 23
Role of Nonresolving Inflammation in Hepatocellular Carcinoma Development and Progression Yu, L-X; Ling, Y; Wang, H-Y npj Precis Oncol 2018-02-23 2.07 | Feb 23
Mesenchymal Stromal Cell Therapy for Liver Diseases Alfaifi, M; Eom, YW; Newsome, PN; Koo Baik, S J Hepatol 2018-02-06 2.06 | Feb 16
The Immunology of Hepatocellular Carcinoma Ringelhan, M; Pfister, D; O’Connor, T; Pikarsky, E; Heikenwalder, M Nat Immunol 2018-01-29 2.04 | Feb 2
Non-Alcoholic Steatohepatitis Pathogenesis: Sublethal Hepatocyte Injury as a Driver of Liver Inflammation Ibrahim. SH; Hirsova, P; Gores, GJ Gut 2018-01-24 2.03 | Jan 26
Extrahepatic Cancers and Chronic HCV Infection Pol, S; Vallet-Pichard, A; Hermine, O Nat Rev Gastroenterol Hepatol 2018-01-17 2.02 | Jan 19
Non-Coding RNAs in Hepatocellular Carcinoma: Molecular Functions and Pathological Implications Wong, CM; Tsang, FH; Ng, IO Nat Rev Gastroenterol Hepatol 2018-01-10 2.01 | Jan 12
Is Osteopontin a Friend or Foe of Cell Apoptosis in Inflammatory Gastrointestinal and Liver Diseases? Iida, T; Wagatsuma, K; Hirayama, D; Nakase, H Int J Mol Sci 2018-12-21 2.00 | Jan 5
Current and Future Therapeutic Regimens for Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Younossi, ZM; Loomba, R; Rinella, ME; Bugianesi, E; Marchesini, G; Neuschwander-Tetri, BA; Serfaty, L; Negro, F; Caldwell, SH; Ratziu, V; Corey, KE; Friedman, SL; Abdelmalek, MF; Harrison, SA; Sanyal, AJ; Lavine, JE; Mathurin, P; Charlton, MR; Chalasani, NP; Anstee, QM; Kowdley, KV; George, J; Goodman, ZD; Lindor, K Hepatology 2017-12-09 1.46 | Dec 15
Human Hepatocyte Transplantation for Liver Disease: Current Status and Future Perspectives Iansante, V; Mitry, RR; Filippi, C; Fitzpatrick, E; Dhawan, A Pediatr Res 2017-12-06 1.45 | Dec 8
Liver Cell Therapy: Is This the End of the Beginning? Alwahsh, SM; Rashidi, H; Hay, DC Cell Mol Life Sci 2017-11-27 1.44 | Dec 1
Hepatitis E Virus: Advances and Challenges Nimgaonkar, I; Ding, Q; Schwartz, RE; Ploss, A Nat Rev Gastroenterol Hepatol 2017-11-22 1.43 | Nov 24
Human Hepatocyte Transplantation for Liver Disease: Current Status and Future Perspectives Iansante, V; Mitry, RR; Filippi, C; Fitzpatrick, E; Dhawan, A Pediatr Res 2017-11-14 1.42 | Nov 17
Mitogen-Activated Protein Kinase Regulation in Hepatic Metabolism Lawan, A; Bennett, AM Trends Endocrinol Metab 2017-11-08 1.41 | Nov 10
Human Hepatic Stellate Cell Isolation and Characterization Shang, L; Hosseini, M; Liu, X; Kisseleva, T; Brenner, DA J Gastroenterol 2017-11-01 1.40 | Nov 3
Nonalcoholic Steatohepatitis (NASH) and Hepatic Fibrosis: Emerging Therapies Wattacheril, J; Issa, D; Sanyal, A Annu Rev Pharmacol Toxicol 2017-10-20 1.39 | Oct 27
Dysregulated Long Noncoding RNAs (lncRNAs) in Hepatocellular Carcinoma: Implications for Tumorigenesis, Disease Progression, and Liver Cancer Stem Cells Huo, X; Han, S; Wu, G; Latchoumanin, O; Zhou, G; Hebbard, L; George, J; Qiao, L Mol Cancer 2017-10-23 1.39 | Oct 27
Hepatitis B Virus and DNA Damage Response: Interactions and Consequences for the Infection Gómez-Moreno, A; Garaigorta, U Viruses 2017-10-19 1.38 | Oct 20
Cholangiocarcinoma — Evolving Concepts and Therapeutic Strategies Rizvi, S; Khan, SA; Hallemeier, CL; Kelley, RK; Gores, GJ Nat Rev Clin Oncol 2017-10-10 1.37 | Oct 13
Statins and Liver Disease: Is it Time to Recommend Statins to Prevent Liver Disease Progression? Price, JC; Tien, PC Am J Gastroenterol 2017-10-05 1.36 | Oct 6
Ribosomal Proteins: Insight into Molecular Roles and Functions in Hepatocellular Carcinoma Xie, X; Guo, P; Yu, H; Wang, Y; Chen, G Oncogene 2017-09-25 1.35 | Sep 29
Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells Castelli, G; Pelosi, E; Testa, U Genes (Basel) 2017-09-20 1.34 | Sep 22
Response to Hepatitis B Vaccination in Patients with Liver Cirrhosis Aggeletopoulou, I; Davoulou, P; Konstantakis, C; Thomopoulos, K; Triantos, C Rev Med Virol 2017-09-14 1.33 | Sep 15
Insulin Regulation of Gluconeogenesis Hatting, M; Tavares, CDJ; Sharabi, K; Rines, AK; Puigserver, P Ann N Y Acad Sci 2017-09-03 1.32 | Sep 8
Epigenetics in Chronic Liver Disease Boyle, M; Mann, J J Hepatol 2017-08-27 1.31 | Sep 1
The Biology of Hepatocellular Carcinoma: Implications for Genomic and Immune Therapies Khemlina, G; Ikeda, S; Kurzrock, R Mol Cancer 2017-08-30 1.31 | Sep 1
Non-Alcoholic Fatty Liver Disease Promotes Hepatocellular Carcinoma through Direct and Indirect Effects on Hepatocytes Ma, C; Zhang, Q; Greten, TF FEBS J 2017-08-31 1.31 | Sep 1
Modeling Inborn Errors of Hepatic Metabolism Using Induced Pluripotent Stem Cells Pournasr, B; Duncan, SA Arterioscler Thromb Vasc Biol 2017-08-17 1.30 | Aug 25
Progress and Prospects of Circular RNAs in Hepatocellular Carcinoma: Novel Insights into their Function Hu J; Li P; Song Y; Ge YX; Meng XM; Huang C; Li J; Xu T J Cell Physiol 2017-08-19 1.30 | Aug 25
Mechanisms of Hepatitis B Virus Persistence Tsai, K-N; Kuo, C-F; Jing-Hsiung, JO Trends Microbiol 2017-08-16 1.29 | Aug 18
Protein Glycosylation in Viral Hepatitis-Related Hepatocellular Carcinoma: Characterization of Heterogeneity, Biological Roles, and Clinical Implications Zhang, S; Cao, X; Gao, Q; Liu, Y Cancer Lett 2017-08-05 1.28 | Aug 11
Mechanosensing in Liver Regeneration Song, Z; Gupta, K; Ng, IC; Xing, J; Yang, YA; Yu, H Semin Cell Dev Biol 2017-07-30 1.27 | Aug 4
Regulation of Hepatic Glucose Metabolism in Health and Disease Petersen, MC; Vatner, DF; Shulman, GI Nat Rev Endocrinol 2017-07-21 1.26 | Jul 28
A Novel Perspective on the ApoM-S1P Axis, Highlighting the Metabolism of ApoM and Its Role in Liver Fibrosis and Neuroinflammation Hajny, S; Christoffersen, C Int J Mol Sci 2017-07-27 1.26 | Jul 28
Stable Isotope-Based Flux Studies in Nonalcoholic Fatty Liver Disease McCullough, A; Previs, S; Kasumov, T Pharmacol Ther 2017-07-15 1.25 | Jul 21
Radiation-Induced Liver Disease: Current Understanding and Future Perspectives Kim, J; Jung, Y Exp Mol Med 2017-07-21 1.25 | Jul 21
Metastasis ‘Systems’ Biology: How Are Macro-environmental Signals Transmitted into Microenvironmental Cues for Disseminated Tumor Cells? Grzelak, CA; Ghajar, CM Curr Opin Cell Biol 2017-07-14 1.25 | Jul 21
Probing the Unseen Structure and Function of Liver Cells Through Atomic Force Microscopy Braet, F1; Taatjes, DJ; Wisse, E3 Semin Cell Dev Biol 2017-07-06 1.24 | Jul 14
Programmed Cell Death 1 (PD-1) and Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Viral Hepatitis Cho, H; Kang, H; Lee, HH; Kim, CW Int J Mol Sci 2017-07-13 1.24 | Jul 14
The Gut Microbiome and Liver Cancer: Mechanisms and Clinical Translation Yu, LX; Schwabe, RF Nat Rev Gastroenterol Hepatol 2017-07-05 1.23 | Jul 7
Targeting the Hepatocyte Growth Factor/Met Pathway in Cancer De Silva, DM; Roy, A; Kato, T; Cecchi, F; Lee, YH; Matsumoto, K; Bottaro, DP Biochem Soc Trans 2017-07-03 1.23 | Jul 7
HMGB1 is a Promising Therapeutic Target for Acute Liver Failure Yamamoto, T; Tajima, Y Expert Rev Gastroenterol Hepatol 2017-06-28 1.22 | Jun 30
Cancer Stem Cells in Hepatocellular Carcinoma Yagci, T; Cetin, M; Ercin, PB J Gastrointest Cancer 2017-06-23 1.22 | Jun 30
Extracellular Vesicles in Liver Disease and Potential as Biomarkers and Therapeutic Targets Szabo, G; Momen-Heravi, F Nat Rev Gastroenterol Hepatol 2017-06-21 1.21 | Jun 23
Systematic Review with Meta-Analysis: The Efficacy and Safety of Stem Cell Therapy for Crohn’s Disease Qiu, Y; Li, MY; Feng, T; Feng, R; Mao, R; Chen, BL; He, Y; Zeng, ZR; Zhang, SH; Chen, MH Stem Cell Res Ther 2017-06-06 3.22 | Jun 16
Engineering In Vitro Models of Hepatofibrogenesis Mazza, G; Al-Akkad, W; Rombouts, K Adv Drug Deliv Rev 2017-05-31 1.19 | Jun 9
The Therapeutic Targeting of HGF/c-Met Signaling in Hepatocellular Carcinoma: Alternative Approaches Hu, CT; Wu, JR; Cheng, CC; Wu, WS Cancers 2017-05-26 1.19 | Jun 9
Targeting Nuclear Receptors for the Treatment of Fatty Liver Disease Tanaka, N; Aoyama, T; Kimura, S; Gonzalez, FJ Pharmacol Ther 2017-05-23 1.18 | Jun 2
Roles of Diacylglycerols and Ceramides in Hepatic Insulin Resistance Peterson, MC; Shulman, GI Trends Pharmacol Sci 2017-05-24 1.17 | May 26
Understanding Liver Regeneration to Bring New Insights to the Mechanisms Driving Cholangiocarcinoma Guest, RV; Boutler, L; Dwyer, BJ; Forbes, SJ NPJ Regen Med 2017-05-22 1.17 | May 26
Hepatocyte Polyploidization and Its Association with Pathophysiological Processes Wang, Min-Jun; Chen, F; Lau, JTY; Hu, Y-P Cell Death Dis 2017-05-18 1.16 | May 19
Mechanisms of Hepatic Stellate Cell Activation Tsuchida, T; Friedman, SL Nat Rev Gastroenterol Hepatol 2017-05-10 1.15 | May 12
Toll Like Receptor 4 and Hepatocellular Carcinoma; A Systematic Review Sepehri, Z; Kiani, Z; Kohan, F; Alavian, SM; Ghavami, S Life Sci 2017-05-01 1.14 | May 5
Effect of Liver Disease on Hepatic Transporter Expression and Function Thakkar, N; Slizgi, JR; Brouwer, KLR J Pharm Sci 2017-04-29 1.14 | May 5
Non-Coding RNA in Hepatocellular Carcinoma: Mechanisms, Biomarkers and Therapeutic Targets Klingenberg, M; Matsuda, A; Diederichs, S; Patel, T J Hepatol 2017-04-21 1.13 | Apr 28
Lipid Droplets and Liver Disease: From Basic Biology to Clinical Implications Gluchowski, NL; Becuwe, M; Walther, TC; Farese Jr, RV Nat Rev Gastroenterol Hepatol 2017-04-21 1.12 | Apr 21
Unraveling the Regulation of Hepatic Metabolism by Insulin Titchenell, PM; Lazar, MA; Birnbaum, MJ Trends Endocrinol Metab 2017-04-14 1.12 | Apr 21
Biomarkers in Hepatocellular Carcinoma: An Overview Juárez-Hernández, E; Motola-Kuba, D; Chávez-Tapia, NC; Uribe, M; Barbero-Becerra, VJ Expert Rev Gastroenterol Hepatol 2017-03-27 1.11 | Apr 6
New Knowledge of the Mechanisms of Sorafenib Resistance in Liver Cancer Zhu, YJ; Zheng, B; Wang, HY; Chen, L Acta Pharmacol Sin 2017-03-27 1.10 | Mar 31
Liver Macrophages in Tissue Homeostasis and Disease Krenkel, O; Tacke, F Nat Rev Immunol 2017-03-20 1.09 | Mar 24
Hepatitis C-Related Hepatocellular Carcinoma in the Era of New Generation Antivirals Baumert, TF; Jühling, F; Ono, A; Hoshida, Y BMC Med 2017-03-14 1.08 | Mar 17
Targeting Hepatic Macrophages to Treat Liver Diseases Tacke. F J Hepatol 2017-03-04 1.07 | Mar 10
Hepatostat: Liver Regeneration and Normal Liver Tissue Maintenance Michalopoulos, GK Hepatology 2017-03-06 1.07 | Mar 10
Non-Alcoholic Fatty Liver Disease Neuschwander-Tetri, BA BMC Med 2017-02-28 1.06 | Mar 3
Non-Alcoholic Fatty Liver Disease: An Emerging Driving Force in Chronic Kidney Disease Targher, G; Byrne, CD Nat Rev Nephrol 2017-02-20 1.05 | Feb 24
New Advances in Polycystic Liver Diseases Santos-Laso, A; Izquierdo-Sánchez, L; Lee-Law, PY; Perugorria, MJ; Marzioni, M; Marin, JJ; Bujanda, L; Banales, JM Semin Liver Dis 2017-02-15 1.05 | Feb 24
Regression of Liver Fibrosis Campana, L; Iredale, JP Semin Liver Dis 2017-02-15 1.04 | Feb 17
The Role of Akt in Chronic Liver Disease and Liver Regeneration Morales-Ruiz, M; Santel, A; Ribera, J; Jiménez, W Semin Liver Dis 2017-02-15 1.04 | Feb 17
The Diversity and Plasticity of Adult Hepatic Progenitor Cells and Their Niche Chen, J; Chen, L; Zern, MA; Thiese, ND; Diehl, AM; Liu, P; Duan, Y Liver Int 2017-01-30 1.03 | Feb 10
The Evolving Concept of Liver Cancer Stem Cells Nio, K; Yamashita, T; Kaneko, S Mol Cancer 2017-01-30 1.02 | Feb 3
Effects of Natural Products on Fructose-Induced Nonalcoholic Fatty Liver Disease (NAFLD) Chen, Q; Wang, T; Li, J; Wang, S; Qiu, F; Yu, H; Zhang, Y; Wang, T Nutrients 2017-01-31 1.02 | Feb 3
Molecular Bases Underlying the Hepatoprotective Effects of Coffee Salomone, F; Galvano, F; Li Volti, G Nutrients 2017-01-23 1.01 | Jan 27
Biology and Function of Glypican-3 as a Candidate for Early Cancerous Transformation of Hepatocytes in Hepatocellular Carcinoma Montalbano, M; Georgiadis, J; Masterson, AL; McGuire, JT; Prajapati, J; Shirafkan, A; Rastellini, C; Cicalese, L Oncol Rep 2017-01-18 1.00 | Jan 20